Beam therapeutics to hold conference call to discuss third quarter 2024 financial results and abstracts accepted for presentation at ash annual meeting

Cambridge, mass., oct. 29, 2024 (globe newswire) -- beam therapeutics inc. (nasdaq: beam), a biotechnology company developing precision genetic medicines through base editing, today announced the company will host a conference call and webcast on tuesday, november 5, 2024, at 8:30 a.m. et to discuss its third quarter 2024 financial results and review the company's abstracts accepted for presentation at the upcoming 66th annual meeting of the american society for hematology (ash).
ASH Ratings Summary
ASH Quant Ranking